The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12620000410954
Ethics application status
Approved
Date submitted
15/03/2020
Date registered
27/03/2020
Date last updated
27/03/2020
Date data sharing statement initially provided
27/03/2020
Type of registration
Retrospectively registered

Titles & IDs
Public title
Use of novel device in the endoscopic treatment of Zenker's Diverticulum patients
Scientific title
Functional Lumen Imaging Probe demonstrates reduced cricopharyngeal distensibility and myotomy-induced improvement in Zenker’s Diverticulum patients
Secondary ID [1] 300800 0
Nil known
Universal Trial Number (UTN)
U1111-1249-8086
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Zenker diverticulum 316672 0
Condition category
Condition code
Oral and Gastrointestinal 314913 314913 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
FLIP (functional lumen imaging probe) measures intestinal distensibility measurements. It has been used in a variety of clinical applications, and has previously been shown to discriminate outcomes from treatment of other oesophageal pathologies including achalasia and oesophageal strictures.
At our facility, FLIP measurements were performed pre- and post-therapeutic endoscopy procedures for dysphagic patients as part of standard care. This includes Zenker patients as well as patients with benign oesophageal strictures and achalasia.
For Zenker patients as relevant to our study, FLIP measurements will be performed during flexible endoscopy cricopharyngeal myotomy. Measurements will be performed by a senior gastroenterologist with expertise in oesophageal pathologies and advanced endoscopic techniques. Patients will be anaesthetised during the procedure by an anaesthesiologist(as is standard for endoscopic myotomy) and FLIP measurements will be taken immediately pre- and post-myotomy. FLIP measurements add approximately 10 minutes to procedure length, and will be performed as a single assessment during the procedure.
Intervention code [1] 317122 0
Not applicable
Comparator / control treatment
A historical control group was used. Our facility prospectively maintains data on distensibility measurements. Non-dysphagic patients were identified who had presented for review at our outpatient clinic and had distensibility measurements taken during routine diagnostic gastroscopy. These patients were screened for and data collected between February 2012 and February 2015.
Control group
Historical

Outcomes
Primary outcome [1] 323228 0
Cricopharyngeal distensibility as assessed by FLIP measurements.
Timepoint [1] 323228 0
Measurements will be taken at the time of gastroscopy for both groups. For the Zenker's diverticulum patients, FLIP measurements will be performed immediately before and after endoscopy myotomy. For the control group, measurements will be performed on completion of the diagnostic gastroscopy.
Secondary outcome [1] 381231 0
Clinical assessment of symptom severity (using modified Dakkak and Bennett scale)


Timepoint [1] 381231 0
Symptoms will be assessed pre-procedure and then again at 1 month post-myotomy.

Secondary outcome [2] 381232 0
Pre-operative and post-operative diverticulum size (classified using the Morton & Bartley classification system on the basis of barium swallow studies)
Timepoint [2] 381232 0
Diverticulum size will be assessed pre-procedure then at 1 month post-myotomy.
Secondary outcome [3] 381233 0
Procedural time measured from time of anaesthesia commencement to cessation. This was determined from routinely collected endoscopy suite documentation of time in/time out.
Timepoint [3] 381233 0
At completion of gastroscopy.
Secondary outcome [4] 381234 0
Adverse events including major (e.g. perforation, bleeding requiring transfusion, sepsis) and minor (e.g. pain, minor bleeding). These will be assessed through medical records.
Timepoint [4] 381234 0
Adverse events are screened for during routine follow up of patients up to 12 months following procedure.

Eligibility
Key inclusion criteria
Treatment naive Zenker's diverticulum patients undergoing flexible endoscopic cricopharyngeal myotomy
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Patients without radiologically proven presence of Zenker diverticulum.
Patients who have previously had endoscopic or surgical treatment of Zenker diverticulum

Study design
Purpose
Duration
Selection
Timing
Both
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 16126 0
St George Hospital - Kogarah
Recruitment hospital [2] 16127 0
St George Private Hospital - Kogarah
Recruitment postcode(s) [1] 29645 0
2217 - Kogarah

Funding & Sponsors
Funding source category [1] 305257 0
Hospital
Name [1] 305257 0
St George Hospital
Country [1] 305257 0
Australia
Primary sponsor type
Individual
Name
Linda Zhang
Address
St George Hospital
Gray St Kogarah NSW 2217
Country
Australia
Secondary sponsor category [1] 305618 0
None
Name [1] 305618 0
Address [1] 305618 0
Country [1] 305618 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 305599 0
Human Research Ethics Committee Prince of Wales Hospital
Ethics committee address [1] 305599 0
Ethics committee country [1] 305599 0
Australia
Date submitted for ethics approval [1] 305599 0
27/09/2018
Approval date [1] 305599 0
09/11/2018
Ethics approval number [1] 305599 0
HREC ref no 18/199

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 100918 0
Dr Linda Zhang
Address 100918 0
St George Hospital
Gray St Kogarah
NSW 2217
Country 100918 0
Australia
Phone 100918 0
+61413168598
Fax 100918 0
Email 100918 0
Contact person for public queries
Name 100919 0
Linda Zhang
Address 100919 0
St George Hospital
Gray St Kogarah NSW 2217
Country 100919 0
Australia
Phone 100919 0
+61 0291131111
Fax 100919 0
Email 100919 0
Contact person for scientific queries
Name 100920 0
Linda Zhang
Address 100920 0
St George Hospital
Gray St Kogarah
NSW 2217
Country 100920 0
Australia
Phone 100920 0
+610291131111
Fax 100920 0
Email 100920 0

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
Only grouped data will be shared.


What supporting documents are/will be available?

Doc. No.TypeCitationLinkEmailOther DetailsAttachment
7365Ethical approval    379465-(Uploaded-15-03-2020-14-16-53)-Study-related document.pdf



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.